Skip to main content
Wenyin Shi, MD, Radiation Oncology, Philadelphia, PA

WenyinShiMD

Radiation Oncology Philadelphia, PA

Benign Diseases, Central Nervous System Cancer, Hematologic Malignancies, Melanoma

Associate Professor, Radiation Oncology, Jefferson Medical College-Thos Jefferson Univ

Dr. Shi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shi's full profile

Already have an account?

  • Office

    111 S 11th St
    # Bodine
    Philadelphia, PA 19107
    Phone+1 215-955-6702
    Fax+1 215-955-5331

Education & Training

  • University of Florida
    University of FloridaResidency, Radiation Oncology, 2006 - 2010
  • University of Florida College of Medicine
    University of Florida College of MedicineInternship, Transitional Year, 2005 - 2006
  • Shanghai Medical University
    Shanghai Medical UniversityClass of 1997

Certifications & Licensure

  • DE State Medical License
    DE State Medical License Current
  • NJ State Medical License
    NJ State Medical License 2017 - 2025
  • PA State Medical License
    PA State Medical License 2010 - 2024
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
  • CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Multi-Institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients with Brain Metastases  
    Simon S Lo, Wenyin Shi, Kristin J Redmond, Mitchell Machtay, JAMA Oncology

Authored Content

  • A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is VirtualJune 2021

Press Mentions

  • Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survival Compared to Matched-Control Patients from EF-14 Trial
    Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survival Compared to Matched-Control Patients from EF-14 TrialMarch 24th, 2022
  • Why Is Glioblastoma Such a Tough Nut to Crack?
    Why Is Glioblastoma Such a Tough Nut to Crack?December 24th, 2019
  • Over 1,000 Multiple Brain Metastases Patients Treated with Brainlab Indication-Specific Software
    Over 1,000 Multiple Brain Metastases Patients Treated with Brainlab Indication-Specific SoftwareNovember 16th, 2017
  • Join now to see all

Professional Memberships

Other Languages

  • Chinese (Mandarin)